公司资料
Icosavax 股价、新闻与催化剂
- 股票代码:
- ICVX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for ICVX.
公司概览
业务概览
Icosavax was a vaccine biotechnology company focused on next-generation respiratory vaccines before its acquisition by AstraZeneca. Its platform combined structural biology and vaccine design.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ before acquisition, Icosavax sat in vaccine biotechnology.
商业模式特征
The business depended on clinical data, immunogenicity, and the value of its vaccine design platform.
生物医药行业定位
Icosavax was a vaccine-platform name and now belongs to biotech M&A history.
未来催化剂
- Icosavax is now mostly a transaction closeout and integration story, so the remaining catalysts are any wind-down or post-deal milestone. There is no live standalone pipeline story left to drive the name.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。